Dr. Matthew J. Reilley
Claim this profileUniversity of Virginia Cancer Center
Studies Cancer
Studies Pancreatic Cancer
16 reported clinical trials
43 drugs studied
Area of expertise
1Cancer
Stage IV
KRAS positive
BRAF positive
2Pancreatic Cancer
Stage IV
KRAS positive
BRAF positive
Affiliated Hospitals
Clinical Trials Matthew J. Reilley is currently running
NDI-219216
for Cancer
The goal of this clinical trial is to learn if NDI-219216 is safe for patients, and if NDI-219216 might be a possible treatment for advanced solid tumors in the later phases of the study. The main questions it aims to answer are: Is NDI-219216 safe and what kinds of side effects might it cause? What kind of effects does NDI-219216 have on the body? Does NDI-219216 have any impact on tumor size? Participants will: Take NDI-219216 every day by mouth. Visit the clinic 6 times during Cycle 1, 2 times during Cycle 2, once a month thereafter for checkups and tests while on the study, then one time for an end of treatment visit. After the End of Study, a follow up will occur but can be done on the phone. Keep a diary of their tablet consumption and symptoms experienced.
Recruiting1 award Phase 1 & 22 criteria
Ipatasertib + Chemotherapy
for Cancer
This phase II ComboMATCH treatment trial tests the usual treatment of chemotherapy (paclitaxel) plus ipatasertib in patients with solid tumor cancers that that cannot be removed by surgery (unresectable), has spread to nearby tissue or lymph nodes (locally advanced) or from where it first started (primary site) to other places in the body (metastatic), and has PTEN and AKT genetic changes. Chemotherapy drugs, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Targeted therapy, such as Ipatasertib, may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. The addition of ipatasertib to paclitaxel in solid tumors with PTEN and AKT genetic changes could increase the percentage of tumors that shrink as well as lengthen the time that the tumors remain stable (without progression). Researchers hope to learn if paclitaxel plus ipatasertib will shrink this type of cancer or stop its growth.
Recruiting1 award Phase 2
More about Matthew J. Reilley
Clinical Trial Related1 year of experience running clinical trials · Led 16 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Matthew J. Reilley has experience with
- Oxaliplatin
- Fluorouracil
- Binimetinib
- Palbociclib
- Pembrolizumab
- Leucovorin
Breakdown of trials Matthew J. Reilley has run
Cancer
Pancreatic Cancer
Solid Tumors
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew J. Reilley specialize in?
Matthew J. Reilley focuses on Cancer and Pancreatic Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are KRAS positive.
Is Matthew J. Reilley currently recruiting for clinical trials?
Yes, Matthew J. Reilley is currently recruiting for 5 clinical trials in Charlottesville Virginia. If you're interested in participating, you should apply.
Are there any treatments that Matthew J. Reilley has studied deeply?
Yes, Matthew J. Reilley has studied treatments such as Oxaliplatin, Fluorouracil, Binimetinib.
What is the best way to schedule an appointment with Matthew J. Reilley?
Apply for one of the trials that Matthew J. Reilley is conducting.
What is the office address of Matthew J. Reilley?
The office of Matthew J. Reilley is located at: University of Virginia Cancer Center, Charlottesville, Virginia 22908 United States. This is the address for their practice at the University of Virginia Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.